News

UCPA Offers New Solutions for Patients with Incontinence

Urology of Central PA now offers new solutions for patients who suffer from incontinence thanks to technology advancements in sacral neuromodulations (SNM) therapy from Medtronic.

UCPA physicians have used InterStim technology for years to treat overactive bladder (OAB), incontinence and fecal incontinence. Recently, the FDA approved the new InterStim™ Micro neurostimulator and InterStim SureScan™ MRI leads and UCPA physicians, Dr. Vanessa Elliott and Dr. Peter Tucker, were able to use the new technology to increase the quality of life for patients in Central PA.

InterStim Micro — the market’s smallest rechargeable sacral neuromodulation therapy device — treats overactive bladder (OAB), fecal incontinence (FI) and non-obstructive urinary retention. The InterStim SureScan MRI leads are used with InterStim Micro and with the recharge-free InterStim II, and allow conditional full-body 1.5 and 3 Tesla MRI scans*.

Patients and physicians now have a choice in InterStim systems — both with conditional full-body MRI — to match the patient’s preferences, lifestyle and treatment goals. The InterStim™ II recharge-free system offers patients freedom from a recharging routine and the hassle of recharging components. The new rechargeable InterStim™ Micro system may be preferred by patients who want a smaller, longer lasting device.

The new InterStim™ Micro:

  • Is 50% smaller (2.8 cm3) than the market’s other rechargeable SNM device and is 80% smaller than InterStim II.
  • Can be recharged once a week, or as infrequently as once per month, depending on the patient’s preference or device settings.
  • Does not require impedance checks prior to an MRI scan.
  • Can recharge from zero to 100% in less than an hour.
  • Reduces the need for battery replacement surgeries due to its life of 15 years.

“Effective long-term bladder and bowel control is an unmet medical need by many in the Central PA area who experience regular accidents and/or frequency issues associated with overactive bladder and fecal incontinence. It can significantly impact all aspects of a person’s quality of life – self-confidence, exercise, activities and even intimacy,” said Vanessa Elliott, M.D.

Peter Tucker, M.D., shared, “By partnering with Medtronic and using new advancements in technology, like their InterStim Micro ™, Urology of Central PA provides patients a better quality of life.”

Not every patient receives the same benefit, and there are potential risks, which may include surgical, device and stimulation risks. See full safety information.

To learn more about UCPA’s approach and treatment options for incontinence and overactive bladder, contact us today!

Leave a Reply

Your email address will not be published. Required fields are marked *